Related Experiment Videos
[A case of T-cell prolymphocytic leukemia]
Summary
This case study describes T-cell prolymphocytic leukemia (T-PLL) in a 54-year-old man. Despite initial chemotherapy response, the patient
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive lymphoid malignancy.
- Diagnosis often relies on specific immunophenotypic and genotypic markers.
Observation:
- A 54-year-old male presented with dyspnea, skin eruption, lymphadenopathy, and hepatosplenomegaly.
- Peripheral blood showed 99% lymphoid cells with a T-cell phenotype (CD2+, CD3-, CD4+, CD7+, CD8-).
- Monoclonal T-cell receptor beta-chain gene rearrangement confirmed clonality.
Findings:
- The patient was diagnosed with T-cell prolymphocytic leukemia.
- Human T-cell lymphotropic virus type 1 (HTLV-1) was not detected.
- Skin lesions and lymph nodes showed infiltration by leukemic T-cells, positive for anti-MT1 antibody.
Implications:
- This case highlights the diagnostic challenges and aggressive nature of T-PLL.
- Combination chemotherapy provided temporary clinical improvement.
- Further research into T-PLL pathogenesis and treatment is warranted.